Na tej stronie
UFPT UFP Technologies, Inc. - Common Stock
NASDAQ · Health Care · Wyświetl na SEC EDGAR ↗ zamknij Paź 2, 2026 10-K/10-Q Sie 6, 2026
$300,70
· % zakresu 52 tyg.
· powyżej minimum
· do maksimum
$173,8652tyg. minimum
$338,7152tyg. maksimum
Kapitalizacja Rynkowa (MRQ)
$2.33B
P/E (TTM)
32.4
EPS (TTM)
$9.28
Przychody (TTM)
$632M
Twoje odznaki
Zakres 52 tyg.
$174–$339
Ocena Analityków
BUY
Cena Docelowa
$355
P/E
32.4
ROE
17.1%
Marża Zysku Netto
11.4%
Twój pasek odznak jest pusty — przypnij metrykę w dowolnym miejscu na tej stronie.
UFPT Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$300.70
Kapitalizacja Rynkowa (MRQ)
$2.33B
P/E (TTM)
32.4
EPS (TTM)
$9.28
Przychody (TTM)
$632M
ROE (TTM)
17.1%
D/E Dług/Kapitał (MRQ)
0.3
Zakres 52 tyg.
$174–$339
UFPT Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
zakres
kreski
Granularność słupków dostosowuje się do wybranego okresu — najedź kursorem na wykres, aby zobaczyć otwarcia/maksima/minima/zamknięcia dla danego słupka.
O UFP Technologies, Inc. - Common Stock Przegląd firmy z Wikipedii
UFP Technologies, Inc. is an American multinational developer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products.
UFP Technologies manufactures a wide range of single-use medical devices, components, and packaging for minimally invasive surgery, infection prevention, wound care, wearables, orthopedic soft goods, and orthopedic implants.
The company also provides highly engineered products and components to customers in the automotive, aerospace and defense, consumer, electronics, and industrial markets.
History
1963-1975
United Packaging Corporation was founded in 1963 by William H. Shaw, Robert W. Drew, and Richard L. Bailly in Woburn, MA as a manufacturer of protective packaging, primarily for electronics. In 1964, the company expanded operations and moved its factory headquarters to Georgetown, Massachusetts. In 1967, the company changed its name to United Foam Plastics Corporation to reflect a broader market capability.
1976-1983
In 1976, with a focus on foam fabrication, the company started precision molding cross-linked polyethylene foam components for the military, consumer, and industrial markets.
1984-1993
In 1988 UFP Technologies introduced compression molded medical protective packaging using specialized foams. On December 17, 1993 the company completed its IPO and formally changed its name to UFP Technologies, Inc. Acquisitions brought new, highly specialized materials including various foams, films, and fabrics used in a range of medical, military, aerospace, consumer, and automotive applications. Additionally, UFP added molded pulp packaging to its portfolio through the acquisition of Moulded Fibre Technology out of Portland, ME.
1994-2003
UFP's growing medical customer base prompted its investment in cleanroom production starting in 1994. In 2001 the company introduced thermoplastic polyurethane (TPU) based pouches and bags as an alternative to foam packaging for the orthopedic implant market. Additional acquisitions expanded its medical foams access and capabilities for a range of applications.
2004-2013
UFP continued to focus on the medical market, accounting for 50% of its $100 million revenue by 2008. Between 2008 and 2013, UFP made five acquisitions to continue its foam offering to medical clients. In 2013 the company introduced a new product line called FlexShield®, a TPU based packaging solution for medical devices, instruments, and orthopedic implants.
2014-2024
In 2016 UFP expanded operations and relocated its headquarters to Newburyport, Massachusetts. In 2022 UFP Technologies sold Molded Fiber Business to CKF, Inc.
In 2022 Sales exceeded $300 million and the firm opened a new medical manufacturing operation in Tijuana, Mexico. In 2023, UFP Technologies was added to the S&P SmallCap 600 index. Additional MedTech acquisitions expanded UFP's international footprint to 5 countries and added complete device manufacturing capabilities. As of 2024, its MedTech business accounted for over 90% of revenue.
Acquisitions
1993 - Moulded Fibre Technology
1997 - FCE Industries
1998 - Pacific Foam Technologies
2000 – Simco Industries
2008 - Stephenson & Lawyer
2009 - Advanced Materials Group
2009 - Foamade Industries Inc.
2009 - E.N. Murray
2013 - Packaging Alternatives Corporation
2018 – Dielectrics
2021 - Contech Medical
2021 – DAS Medical
2022 - Advant Medical
2024 - AJR Enterprises
2024 - AQF Medical
2024 - Marble Medical
2024 - Welch Fluorocarbon
2025 - UNIPEC
2025 - Techno Plastics Industries, Inc. (TPI)
Awards & Recognition
The National Association for Business Resources (NABR):
"Best and Brightest Companies to Work for In The Nation" (2024, 2023, 2022, 2021, 2020, and 2018)
"New England's Best & Brightest to Work For" (formerly "Boston's Best & Brightest Companies to Work For") (2024, 2023, 2022, 2021, 2020, and 2018)
"West Michigan's Best & Brightest Companies to Work For" (2024, 2023, 2022, 2021, 2020, 2019 and 2018)
Diversity Jobs' "Top Diversity Employer (2024)
Forbes
"Most Trusted Companies In America" (2025)
"America's Most Successful Small-Cap Companies" (2024, 2024)
Fortune
"100 Fastest-Growing Companies" (2024)
"Small Business 100" (2009 and 2008)
Boston Business Journal "Top 150 Public Companies"
The Boston Globe's "The Globe 100" (2013-2006)
24/7 Wall Street's "100 Best Small Companies in America" (2012)
== References ==
Źródło: Wikipedia (Angielski), CC BY-SA 4.0 · Zobacz w Wikipedii ↗
sektorHealth Care
branżaHealth Care
pracownicy4 846
krajUS
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody$603M2016-12-31 → 2025-12-31
EPS$8.752016-12-31 → 2025-12-31
Wolny przepływ pieniężny·2016-12-31 → 2024-12-31
Marża netto11.4%2016-12-31 → 2025-12-31
Wycena i wskaźniki
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
| Wskaźnik | Trend 5-letni | UFPT | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| P/E (TTM) | 32.4średnia z 5 lat ≈28.5 | ≈28.5 | 37.3 | Niedowartościowany | |
| P/S (TTM) | 3.7średnia z 5 lat ≈2.9 | ≈2.9 | 2.0 | Zawyżona wycena | |
| P/B (MRQ) | 5.0średnia z 5 lat ≈4.0 | ≈4.0 | 1.7 | Zawyżona wycena | |
| EV / EBITDA | 21.7średnia z 5 lat ≈18.0 | ≈18.0 | 20.6 | Niedowartościowany | |
| Price / Cash Flow (Cena / Przepływy pieniężne) | 25.1średnia z 5 lat ≈33.6 | ≈33.6 | 18.9 | Wartość godziwa | |
| EV / Revenue (EV / Przychody) | 4.0średnia z 5 lat ≈3.2 | ≈3.2 | · | · | |
| Cena / Wartość księgowa materialna (MRQ) | 7.1średnia z 5 lat ≈69.0 | ≈69.0 | · | · | |
| PEG Ratio (Współczynnik PEG) | ≈0.9 | · | · | · |
Mediana porównawcza jest obliczana na znormalizowanej podstawie dla każdej metryki i może nie zawsze odpowiadać podstawie TTM/MRQ pokazanej dla tej akcji.
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
| Wskaźnik | Trend 5-letni | UFPT | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Marża brutto (TTM) | 28.5%średnia z 5 lat ≈27.1% | ≈27.1% | 57.3% | Słaby | |
| Marża Operacyjna (TTM) | 15.3%średnia z 5 lat ≈14.3% | ≈14.3% | 8.1% | Najwyższa półka | |
| EBITDA Margin (Marża EBITDA) | 18.5%średnia z 5 lat ≈17.6% | ≈17.6% | 11.7% | Najwyższa półka | |
| Marża przed opodatkowaniem (TTM) | 14.0%średnia z 5 lat ≈13.4% | ≈13.4% | 6.1% | Najwyższa półka | |
| Marża Zysku Netto (TTM) | 11.4%średnia z 5 lat ≈10.8% | ≈10.8% | 3.8% | Najwyższa półka | |
| ROA (TTM) | 11.0%średnia z 5 lat ≈10.2% | ≈10.2% | -3.8% | Najwyższa półka | |
| ROE (TTM) | 17.1%średnia z 5 lat ≈15.4% | ≈15.4% | -5.8% | Najwyższa półka | |
| ROIC | 13.7%średnia z 5 lat ≈12.4% | ≈12.4% | -4.8% | Najwyższa półka |
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
| Wskaźnik | Trend 5-letni | UFPT | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Dług / Kapitał Własny (MRQ) | 0.3średnia z 5 lat ≈0.3 | ≈0.3 | 0.5 | Niski dług | |
| Wskaźnik bieżący (MRQ) | 3.0średnia z 5 lat ≈2.5 | ≈2.5 | 2.7 | Zgodnie z | |
| Quick Ratio (Wskaźnik Szybkości) | 1.4średnia z 5 lat ≈1.3 | ≈1.3 | 1.3 | Silna płynność | |
| Dług długoterminowy / Kapitał własny (MRQ) | 0.2średnia z 5 lat ≈0.3 | ≈0.3 | 0.6 | Niski dług |
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
| Wskaźnik | Trend 5-letni | UFPT | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Revenue YoY (Przychody R/R) | 19.5%średnia z 5 lat ≈29.0% | ≈29.0% | · | · | |
| Revenue CAGR 3Y (Przychody CAGR 3L) | 19.4%średnia z 5 lat ≈28.3% | ≈28.3% | · | · | |
| Revenue CAGR 5Y (Przychody CAGR 5L) | 27.4% | · | · | · | |
| EPS YoY | 15.4%średnia z 5 lat ≈46.3% | ≈46.3% | · | · | |
| Net Income YoY (Zysk Netto R/R) | 15.8%średnia z 5 lat ≈47.3% | ≈47.3% | · | · | |
| EPS CAGR 3Y (CAGR z EPS 3 lata) | 17.1%średnia z 5 lat ≈39.8% | ≈39.8% | · | · | |
| EPS CAGR 5Y (CAGR z EPS 5 lat) | 37.7% | · | · | · | |
| Net Income CAGR 3Y (CAGR z zysku netto 3 lata) | 17.8%średnia z 5 lat ≈40.8% | ≈40.8% | · | · | |
| Net Income CAGR 5Y (CAGR z zysku netto 5 lat) | 38.6% | · | · | · |
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
| Wskaźnik | Trend 5-letni | UFPT | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Asset Turnover (Rotacja aktywów) | 0.9średnia z 5 lat ≈0.9 | ≈0.9 | 0.5 | Najwyższa półka | |
| Inventory Turnover (Rotacja zapasów) | 5.0średnia z 5 lat ≈5.2 | ≈5.2 | 2.3 | Najwyższa półka | |
| Receivables Turnover (Rotacja należności) | 7.2średnia z 5 lat ≈6.9 | ≈6.9 | 6.4 | Zgodnie z | |
| Revenue / Employee (Przychody / pracownika) | ≈$124.4K | · | · | · |
wartość · ≈ średnia z 5 lat · mediana branżowa · werdykt względem mediany
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
6.8%
Następny raport
Lis 02, 2026
| Okres | Raport | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|---|
| 30 czerwca 2026 | Sie 3, 2026 | $2.92 | $2.54 | 14.7% |
| 31 marca 2026 | $2.48 | $2.29 | 8.2% | |
| 31 grudnia 2025 | $2.25 | $2.13 | 5.5% | |
| 30 września 2025 | $2.11 | $2.09 | 0.91% | |
| 30 czerwca 2025 | $2.21 | $2.15 | 2.9% | |
| 31 marca 2025 | $2.21 | $2.04 | 8.3% |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $603M | $504M | $400M | $354M | $206M | $179M | $198M | $190M | $148M | $146M | $139M | $139M | |
| Cost of Revenue | $432M | $358M | $288M | $264M | $155M | $135M | $144M | $142M | $112M | $111M | $101M | $102M | |
| Gross Profit | $170M | $147M | $112M | $90M | $51M | $45M | $54M | $48M | $35M | $35M | $37M | $37M | |
| R&D Expense | $9M | $10M | $7M | $9M | $8M | $8M | $9M | $10M | $5M | $1M | $1M | $1M | |
| SG&A Expense | $77M | $62M | $51M | $46M | $29M | $27M | $29M | $28M | $24M | $24M | $24M | $24M | |
| Operating Income | $92M | $81M | $58M | $55M | $21M | $17M | $25M | $20M | $12M | $12M | $12M | $12M | |
| Interest Expense | · | $8M | $4M | $3M | $39.0K | $83.0K | $674.0K | $1M | $50.0K | $69.0K | $87.0K | $154.0K | |
| Interest Income | · | · | · | · | $49.0K | $0 | $0 | $47.0K | $216.0K | $149.0K | $114.0K | $46.0K | |
| Other Non-op | $-21.0K | $189.0K | $-117.0K | $81.0K | $26.0K | $-366.0K | $-388.0K | $64.0K | · | · | $27.0K | $312.0K | |
| Pretax Income | $83M | $73M | $54M | $53M | $21M | $16M | $24M | $18M | $12M | $12M | $12M | $12M | |
| Income Tax | $14M | $14M | $9M | $11M | $5M | $3M | $4M | $4M | $3M | $4M | $4M | $4M | |
| Net Income | $68M | $59M | $45M | $42M | $16M | $13M | $20M | $14M | $9M | $8M | $8M | $8M | |
| EPS (Basic) | $8.87 | $7.69 | $5.89 | $5.52 | $2.11 | $1.79 | $2.66 | $1.95 | $1.27 | $1.11 | $1.07 | $1.08 | |
| EPS (Diluted) | $8.75 | $7.58 | $5.83 | $5.45 | $2.09 | $1.77 | $2.63 | $1.93 | $1.26 | $1.10 | $1.05 | $1.05 | |
| Shares (Basic) | 7,705,000 | 7,668,000 | 7,624,000 | 7,564,000 | 7,524,000 | 7,484,000 | 7,424,000 | 7,347,000 | 7,248,000 | 7,190,000 | 7,102,000 | 7,028,000 | |
| Shares (Diluted) | 7,804,000 | 7,785,000 | 7,701,000 | 7,663,000 | 7,615,000 | 7,568,000 | 7,516,000 | 7,430,000 | 7,337,000 | 7,275,000 | 7,206,000 | 7,175,000 | |
| EBITDA | $111M | $96M | $69M | $67M | $30M | $25M | $33M | $27M | $17M | $18M | · | $16M |
Bilans
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $20M | $13M | $5M | $4M | $11M | $24M | $4M | $3M | $38M | $31M | $30M | $34M | |
| Receivables | $83M | $85M | $64M | $55M | $39M | $26M | $29M | $28M | $21M | $21M | $17M | $16M | |
| Inventory | $87M | $88M | $70M | $54M | $33M | $19M | $18M | $20M | $13M | $14M | $14M | $13M | |
| Prepaid Expense | $6M | $4M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $930.0K | $664.0K | |
| Current Assets | $201M | $195M | $145M | $116M | $87M | $72M | $53M | $56M | $75M | $70M | $63M | $67M | |
| PP&E (Net) | $79M | $71M | $62M | $58M | $57M | $54M | $57M | $58M | $54M | $49M | $47M | $35M | |
| PP&E (Gross) | $152M | $135M | $119M | $111M | $127M | $118M | $116M | $112M | $107M | $97M | $91M | $76M | |
| Accum. Depreciation | $73M | $64M | $57M | $53M | $70M | $65M | $59M | $54M | $53M | $48M | $44M | $41M | |
| Goodwill | $197M | $190M | $113M | $113M | $108M | $52M | $52M | $52M | $7M | $7M | $7M | $7M | |
| Intangibles | $141M | $144M | $64M | $68M | $68M | $20M | $21M | $22M | · | $318.0K | $636.0K | $953.0K | |
| Other Non-current Assets | $3M | $447.0K | $469.0K | $4M | $1M | $153.0K | $147.0K | $201.0K | $144.0K | $153.0K | $2M | $2M | |
| Total Assets | $655M | $629M | $404M | $378M | $334M | $203M | $189M | $190M | $138M | $128M | $120M | $113M | |
| Accounts Payable | $24M | $24M | $22M | $20M | $11M | $4M | $5M | $7M | $4M | $4M | $5M | $5M | |
| Accrued Liabilities | $29M | $30M | $22M | $23M | $17M | $8M | $8M | $8M | $5M | $5M | $5M | $5M | |
| Current Liabilities | $75M | $76M | $58M | $56M | $39M | $15M | $17M | $21M | $10M | $10M | $11M | $12M | |
| Capital Leases | $14M | $12M | $11M | · | $7M | $950.0K | $2M | $0 | · | · | · | · | |
| Deferred Tax | $9M | $3M | $428.0K | $448.0K | $3M | $5M | $5M | $4M | $2M | $3M | $3M | $2M | |
| Other Non-current Liabilities | $4M | $11M | $15M | $18M | $15M | $1M | $334.0K | $24.0K | $82.0K | $184.0K | $171.0K | · | |
| Total Liabilities | $231M | $286M | $118M | $141M | $140M | $26M | $27M | $49M | $14M | $15M | $16M | $18M | |
| Long-term Debt | $135M | $189M | $32M | $55M | $75M | $0 | · | $25M | · | $856.0K | $2M | $3M | |
| Total Debt | $135M | $189M | $32M | $55M | $75M | · | · | $25M | · | $856.0K | · | $3M | |
| Common Stock | $77.0K | $77.0K | $76.0K | $76.0K | $75.0K | $75.0K | $74.0K | $74.0K | $73.0K | $72.0K | $72.0K | $71.0K | |
| Paid-in Capital | $46M | $41M | $39M | $36M | $34M | $32M | $31M | $29M | $27M | $25M | $24M | $22M | |
| Retained Earnings | $375M | $307M | $248M | $203M | $161M | $145M | $132M | $112M | $98M | $88M | $80M | $73M | |
| Treasury Stock | $587.0K | $587.0K | $587.0K | $587.0K | $587.0K | $587.0K | $587.0K | $587.0K | $587.0K | $587.0K | $587.0K | · | |
| AOCI | $4M | $-4M | $268.0K | $-610.0K | $0 | · | · | · | · | · | · | · | |
| Stockholders' Equity | $424M | $343M | $286M | $238M | $194M | $177M | $162M | $140M | $124M | $113M | $104M | $95M | |
| Liabilities + Equity | $655M | $629M | $404M | $378M | $334M | $203M | $189M | $190M | $138M | $128M | $120M | $113M | |
| Shares Outstanding | 7,676,785 | 7,676,785 | 7,639,780 | 7,639,780 | 7,581,685 | 7,500,066 | 7,446,209 | 7,385,443 | 7,280,350 | 7,212,464 | 7,140,818 | 7,068,815 |
Przepływy pieniężne
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $19M | $15M | $11M | $12M | $8M | $8M | $8M | $8M | $6M | $6M | $5M | $4M | |
| Stock-based Comp | $9M | $7M | $5M | $3M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | |
| Deferred Tax | $5M | $1M | $823.0K | $-4M | $-2M | $136.0K | $792.0K | $2M | $-1M | $576.0K | $437.0K | $1M | |
| Amort. of Intangibles | $10M | $7M | $4M | $4M | $1M | $1M | $1M | $1M | $300.0K | $300.0K | $318.0K | $393.0K | |
| Restructuring | · | · | · | · | · | · | · | · | $63.0K | $420.0K | $2M | $2M | |
| Other Non-cash | $-10M | $-15M | $-20M | $-35M | $-11M | $1M | $924.0K | $-4M | $3M | $-6M | · | $-3M | |
| Operating Cash Flow | $92M | $67M | $41M | $18M | $14M | $25M | $31M | $21M | $17M | $9M | $13M | $11M | |
| CapEx | · | $10M | $10M | $14M | $5M | $4M | $6M | $5M | $10M | $7M | $16M | $13M | |
| Investing Cash Flow | $-28M | $-210M | $-10M | $1M | $-101M | $-4M | $-6M | $-82M | $-10M | $-7M | $-16M | · | |
| Debt Issued | $0 | $125M | $0 | $0 | $40M | $0 | $0 | $20M | · | · | · | · | |
| Net Debt Issued | $-12M | $90M | $-4M | $-4M | $40M | $0 | $-17M | $17M | $-856.0K | $-1M | · | $-977.0K | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | $587.0K | · | |
| Financing Cash Flow | $-58M | $152M | $-30M | $-26M | $74M | $-285.0K | $-25M | $26M | $-475.0K | $-559.0K | $-1M | · | |
| Net Change in Cash | $7M | $8M | $812.0K | $-7M | $-13M | $20M | $505.0K | $-35M | $7M | $2M | $-4M | · | |
| Taxes Paid | $4M | $13M | $11M | $13M | $6M | $2M | $1M | $3M | $4M | $4M | $1M | $3M | |
| Free Cash Flow | · | $57M | $31M | $4M | $9M | $21M | $25M | $16M | $7M | $2M | · | $-2M | |
| Levered FCF | · | $50M | $28M | $2M | $9M | $21M | $25M | $15M | $7M | $2M | · | · |
Rentowność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 28.3% | 29.1% | 28.1% | 25.5% | 24.8% | 24.9% | 27.2% | 25.4% | 24.0% | 23.7% | · | 26.5% | |
| Operating Margin | 15.3% | 16.0% | 14.4% | 15.7% | 10.3% | 9.3% | 12.4% | 10.3% | 7.9% | 8.4% | · | 8.3% | |
| Net Margin | 11.3% | 11.7% | 11.2% | 11.8% | 7.7% | 7.4% | 10.0% | 7.5% | 6.2% | 5.5% | · | 5.4% | |
| Pretax Margin | 13.7% | 14.5% | 13.5% | 14.9% | 10.3% | 9.1% | 11.9% | 9.7% | 8.0% | 8.4% | · | 8.5% | |
| EBITDA Margin | 18.5% | 18.9% | 17.3% | 19.0% | 14.4% | 13.9% | 16.6% | 14.4% | 11.7% | 12.2% | · | 11.4% | |
| ROA | 10.6% | 11.4% | 11.5% | 11.7% | 5.9% | 6.8% | 10.4% | 8.7% | 6.9% | 6.4% | · | 6.9% | |
| ROE | 16.9% | 17.6% | 16.1% | 18.0% | 8.2% | 7.6% | 12.4% | 10.4% | 7.8% | 7.4% | · | 8.4% | |
| ROIC | 13.7% | 12.3% | 15.1% | 15.0% | 5.9% | 7.8% | 12.7% | 9.2% | 7.3% | 7.0% | · | 7.6% |
Płynność i wypłacalność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.7 | 2.6 | 2.5 | 2.1 | 2.5 | 4.7 | 3.3 | 2.7 | 7.6 | 7.3 | · | 5.9 | |
| Quick Ratio | 1.4 | 1.3 | 1.2 | 1.1 | 1.5 | 3.3 | 2.0 | 1.5 | 6.0 | 5.5 | · | 4.4 | |
| Debt / Equity | 0.3 | 0.6 | 0.1 | 0.2 | 0.4 | · | · | 0.2 | · | 0.0 | · | 0.0 | |
| LT Debt / Equity | 0.3 | 0.5 | 0.1 | 0.2 | 0.4 | · | · | 0.2 | · | · | · | 0.0 | |
| Interest Coverage | · | 10.0 | 15.8 | 20.1 | 241.1 | 201.6 | 36.7 | 14.9 | 233.9 | 177.3 | · | · |
Efektywność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.9 | 1.0 | 1.0 | 1.0 | 0.8 | 0.9 | 1.0 | 1.2 | 1.1 | 1.2 | · | 1.3 | |
| Inventory Turnover | 5.0 | 4.5 | 4.7 | 6.1 | 6.0 | 7.3 | 7.6 | 8.8 | 8.3 | 7.9 | · | 8.6 | |
| Receivables Turnover | 7.2 | 6.8 | 6.7 | 7.5 | 6.3 | 6.5 | 7.0 | 7.7 | 6.9 | 7.5 | · | 8.3 |
Na akcję
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $54.95 | $44.65 | · | $31.33 | $25.81 | $23.59 | $21.75 | $19.02 | $17.08 | $15.67 | · | $13.44 | |
| Revenue / Share | $77.24 | $64.79 | $51.95 | $46.17 | $27.09 | $23.70 | $26.39 | $25.63 | $20.15 | $20.09 | · | $19.42 | |
| Cash Flow / Share | $11.78 | $8.55 | $5.37 | $2.32 | $1.88 | $3.31 | $4.16 | $2.87 | $2.38 | $1.29 | · | $1.55 | |
| Cash / Share | $2.63 | $1.75 | · | $0.59 | $1.48 | $3.23 | $0.50 | $0.44 | $5.24 | $4.35 | · | $4.82 | |
| EPS (TTM) | $8.75 | $7.58 | $5.83 | $5.45 | $2.09 | $1.77 | $2.63 | $1.93 | $1.26 | $1.10 | $1.05 | $1.05 |
Stopy Wzrostu
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 19.5% | 26.1% | 13.1% | 71.5% | 15.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 19.4% | 34.7% | 30.7% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 27.4% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 15.4% | 30.0% | 7.0% | 160.8% | 18.1% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 17.1% | 53.6% | 48.8% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 37.7% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 15.8% | 31.3% | 7.5% | 163.1% | 18.8% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 17.8% | 54.9% | 49.8% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 38.6% | · | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM)
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $603M | $504M | $400M | $354M | $206M | $179M | $198M | $190M | $148M | $146M | $139M | $139M | |
| Net Income TTM | $68M | $59M | $45M | $42M | $16M | $13M | $20M | $14M | $9M | $8M | $8M | $8M | |
| Market Cap | $1.71B | $1.88B | · | $894M | $529M | $350M | $369M | $222M | $201M | $184M | · | $174M | |
| Enterprise Value | $1.83B | $2.05B | · | $944M | $593M | · | · | $244M | · | $153M | · | $143M | |
| P/E | 25.4 | 32.3 | 29.5 | 21.6 | 33.6 | 26.3 | 18.9 | 15.6 | 22.1 | 23.1 | 22.7 | 23.4 | |
| P/S | 2.8 | 3.7 | · | 2.5 | 2.6 | 1.9 | 1.9 | 1.2 | 1.4 | 1.3 | · | 1.2 | |
| P/B | 4.0 | 5.5 | · | 3.8 | 2.7 | 2.0 | 2.3 | 1.6 | 1.6 | 1.6 | · | 1.8 | |
| P / Tangible Book | 20.0 | 212.1 | · | 15.9 | 27.9 | 3.3 | · | · | · | · | · | · | |
| P / Cash Flow | 18.6 | 28.2 | · | 50.4 | 37.0 | 14.0 | 11.8 | 10.4 | 11.5 | 19.5 | · | 15.6 | |
| P / FCF | · | 33.0 | · | 225.5 | 59.5 | 16.9 | 14.5 | 14.0 | 28.4 | 87.4 | · | -75.2 | |
| EV / EBITDA | 16.4 | 21.5 | · | 14.0 | 20.0 | · | · | 8.9 | · | 8.6 | · | 8.9 | |
| EV / FCF | · | 36.1 | · | 238.2 | 66.7 | · | · | 15.3 | · | 72.9 | · | -61.7 | |
| EV / Revenue | 3.0 | 4.1 | · | 2.7 | 2.9 | · | · | 1.3 | · | 1.0 | · | 1.0 | |
| Earnings Yield | 3.9% | 3.1% | 3.4% | 4.6% | 3.0% | 3.8% | 5.3% | 6.4% | 4.5% | 4.3% | 4.4% | 4.3% |
Rachunek zysków i strat
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $174M | $154M | $149M | $155M | $151M | $148M | $144M | $145M | $110M | $105M | $101M | $101M | $100M | $98M | $91M | $97M | |
| Cost of Revenue | $123M | $110M | $107M | $112M | $108M | $106M | $102M | $104M | $77M | $75M | $75M | $73M | $70M | $69M | $68M | $71M | |
| Gross Profit | $51M | $44M | $42M | $43M | $44M | $42M | $42M | $42M | $33M | $30M | $26M | $28M | $30M | $29M | $23M | $26M | |
| SG&A Expense | $23M | $21M | $21M | $19M | $19M | $19M | $19M | $16M | $14M | $14M | $13M | $12M | $12M | $13M | $12M | $12M | |
| Operating Income | $28M | $23M | $22M | $23M | $24M | $23M | $22M | $25M | $18M | $16M | $13M | $15M | $17M | $13M | $11M | $26M | |
| Interest Expense | · | · | · | · | $3M | $3M | · | $3M | $577.0K | $631.0K | · | $933.0K | $1M | $869.0K | $873.0K | $830.0K | |
| Interest Income | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $11.0K | |
| Other Non-op | $40.0K | $-22.0K | $-31.0K | $78.0K | $-32.0K | $-36.0K | $219.0K | $-70.0K | $-2.0K | $42.0K | $-89.0K | $29.0K | $20.0K | $-77.0K | $-232.0K | $104.0K | |
| Pretax Income | $26M | $22M | $20M | $21M | $22M | $20M | $19M | $21M | $17M | $15M | $12M | $14M | $16M | $12M | $10M | $25M | |
| Income Tax | $6M | $4M | $2M | $5M | $4M | $3M | $3M | $5M | $4M | $3M | $285.0K | $2M | $4M | $2M | $1M | $6M | |
| Net Income | $21M | $17M | $18M | $16M | $17M | $17M | $16M | $16M | $14M | $13M | $12M | $12M | $12M | $10M | $8M | $20M | |
| EPS (Basic) | $2.69 | $2.27 | $2.28 | $2.12 | $2.23 | $2.24 | $2.13 | $2.13 | $1.77 | $1.66 | $1.52 | $1.53 | $1.56 | $1.28 | $1.12 | $2.58 | |
| EPS (Diluted) | $2.68 | $2.24 | $2.25 | $2.11 | $2.21 | $2.21 | $2.10 | $2.11 | $1.75 | $1.64 | $1.51 | $1.52 | $1.55 | $1.27 | $1.10 | $2.56 | |
| Shares (Basic) | 7,740,000 | 7,721,000 | · | 7,712,000 | 7,709,000 | 7,688,000 | · | 7,674,000 | 7,672,000 | 7,651,000 | · | 7,639,000 | 7,625,000 | 7,592,000 | · | 7,570,000 | |
| Shares (Diluted) | 7,788,000 | 7,799,000 | · | 7,780,000 | 7,773,000 | 7,776,000 | · | 7,772,000 | 7,753,000 | 7,737,000 | · | 7,709,000 | 7,690,000 | 7,681,000 | · | 7,638,000 | |
| EBITDA | · | $23M | · | $23M | $29M | $28M | · | $25M | $18M | $19M | · | $15M | $17M | $16M | · | $26M |
Bilans
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $9M | $20M | $20M | $18M | $15M | $14M | $13M | $16M | $17M | $11M | · | $6M | $5M | $7M | · | $10M | |
| Receivables | $113M | $99M | $83M | $85M | $85M | $94M | $85M | $89M | $61M | $61M | · | $61M | $64M | $60M | · | $61M | |
| Inventory | $100M | $94M | $87M | $86M | $85M | $90M | $88M | $89M | $78M | $74M | · | $70M | $63M | $57M | · | $54M | |
| Prepaid Expense | $8M | $8M | $6M | $7M | $5M | $5M | $4M | $5M | $4M | $4M | · | $3M | $5M | $4M | · | $2M | |
| Current Assets | $235M | $224M | $201M | $198M | $191M | $206M | $195M | $201M | $162M | $151M | · | $140M | $137M | $127M | · | $130M | |
| PP&E (Net) | $77M | $78M | $79M | $78M | $74M | $72M | $71M | $70M | $64M | $62M | · | $61M | $60M | $59M | · | $56M | |
| PP&E (Gross) | $155M | $154M | $152M | $149M | $143M | $138M | $135M | $133M | $125M | $121M | · | $118M | $116M | $113M | · | $108M | |
| Accum. Depreciation | $78M | $76M | $73M | $71M | $69M | $67M | $64M | $63M | $61M | $59M | · | $57M | $56M | $54M | · | $51M | |
| Goodwill | $196M | $197M | $197M | $197M | $193M | $191M | $190M | $205M | $116M | $113M | $113M | $113M | $113M | $113M | $113M | $113M | |
| Intangibles | $135M | $138M | $141M | $143M | $142M | $143M | $144M | $135M | $62M | $63M | · | $65M | $66M | $67M | · | $69M | |
| Other Non-current Assets | $5M | $5M | $3M | $3M | $3M | $3M | $447.0K | $436.0K | $414.0K | $413.0K | · | $633.0K | $858.0K | $4M | · | $4M | |
| Total Assets | $682M | $675M | $655M | $653M | $635M | $643M | $629M | $639M | $422M | $408M | · | $400M | $398M | $391M | · | $388M | |
| Accounts Payable | $33M | $28M | $24M | $29M | $23M | $30M | $24M | $26M | $23M | $24M | · | $27M | $25M | $20M | · | $21M | |
| Accrued Liabilities | $23M | $26M | $29M | $30M | $25M | $29M | $30M | $30M | $21M | $16M | · | $19M | $17M | $17M | · | $26M | |
| Current Liabilities | $78M | $77M | $75M | $82M | $69M | $80M | $76M | $78M | $52M | $52M | · | $57M | $53M | $52M | · | $57M | |
| Capital Leases | $14M | $13M | $14M | $14M | $13M | $12M | $12M | $12M | $9M | · | · | · | · | · | · | $10M | |
| Deferred Tax | $14M | $12M | $9M | $8M | $5M | $5M | $3M | $2M | $182.0K | $575.0K | · | $443.0K | $458.0K | $0 | · | $4M | |
| Other Non-current Liabilities | $2M | $2M | $4M | $4M | $4M | $9M | $11M | $11M | $10M | $14M | · | $15M | $15M | $19M | · | $20M | |
| Total Liabilities | $219M | $236M | $231M | $249M | $249M | $282M | $286M | $309M | $112M | $113M | · | $127M | $138M | $144M | · | $162M | |
| Long-term Debt | $117M | $138M | $135M | $146M | $164M | $183M | $189M | $212M | $35M | $34M | · | $43M | $57M | $60M | · | $71M | |
| Total Debt | · | $138M | · | $146M | $164M | $183M | · | $212M | $35M | $34M | · | $43M | $57M | $60M | · | $71M | |
| Common Stock | $77.0K | $77.0K | $77.0K | $77.0K | $77.0K | $77.0K | $77.0K | $77.0K | $77.0K | $77.0K | · | $76.0K | $76.0K | $76.0K | · | $76.0K | |
| Paid-in Capital | $48M | $45M | $46M | $44M | $42M | $39M | $41M | $39M | $37M | $36M | · | $38M | $37M | $35M | · | $35M | |
| Retained Earnings | $413M | $392M | $375M | $357M | $341M | $324M | $307M | $290M | $274M | $260M | · | $236M | $224M | $212M | · | $194M | |
| Treasury Stock | $587.0K | $587.0K | $587.0K | $587.0K | $587.0K | $587.0K | $587.0K | $587.0K | $587.0K | $587.0K | · | $587.0K | $587.0K | $587.0K | · | $587.0K | |
| AOCI | $2M | $2M | $4M | $4M | $3M | $-2M | $-4M | $573.0K | $-497.0K | $-316.0K | · | $-869.0K | $-76.0K | $-117.0K | · | $-3M | |
| Stockholders' Equity | $462M | $439M | $424M | $404M | $385M | $361M | $343M | $329M | $310M | $295M | $286M | $272M | $260M | $246M | $238M | $226M | |
| Liabilities + Equity | $682M | $675M | $655M | $653M | $635M | $643M | $629M | $639M | $422M | $408M | · | $400M | $398M | $391M | · | $388M | |
| Shares Outstanding | 7,745,790 | 7,736,939 | 7,713,300 | 7,712,444 | · | 7,706,825 | 7,676,785 | 7,674,363 | 7,674,363 | 7,670,487 | · | 7,638,812 | 7,638,812 | 7,612,970 | · | 7,578,605 |
Przepływy pieniężne
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | $5M | $5M | $5M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Stock-based Comp | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $838.0K | $897.0K | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-5M | $798.0K | |
| Amort. of Intangibles | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Other Non-cash | · | · | · | · | · | $-10M | · | · | · | $-7M | · | · | · | $-12M | · | · | |
| Operating Cash Flow | $16M | $3M | $17M | $36M | $25M | $14M | $24M | $20M | $12M | $11M | $13M | $18M | $9M | $2M | $18M | $-109.0K | |
| CapEx | · | · | · | · | $3M | $3M | · | $2M | $3M | $2M | · | $3M | $3M | $2M | $3M | $2M | |
| Investing Cash Flow | $-1M | $-2M | $-4M | $-15M | $-6M | $-3M | $-4M | $-197M | $-7M | $-2M | $-3M | $-3M | $-3M | $-2M | $-3M | $33M | |
| Debt Issued | · | · | $0 | · | · | · | $0 | · | · | · | $0 | · | · | · | · | · | |
| Net Debt Issued | · | $-3M | · | · | · | $-3M | · | · | · | $-2M | · | · | · | $-1M | · | · | |
| Financing Cash Flow | $-25M | $-2M | $-11M | $-17M | $-19M | $-11M | $-23M | $177M | $1M | $-3M | $-11M | $-14M | $-7M | $3M | $-21M | $-29M | |
| Net Change in Cash | $-11M | $-325.0K | $2M | $3M | $864.0K | $578.0K | $-3M | $-372.0K | $5M | $6M | $-1M | $1M | $-1M | $2M | $-5M | $4M | |
| Taxes Paid | $3M | $10.0K | $2M | $686.0K | $1M | $-468.0K | $3M | $4M | $6M | $0 | $394.0K | $2M | $8M | $-50.0K | $885.0K | $7M | |
| Free Cash Flow | · | · | · | · | · | $11M | · | · | · | $9M | · | · | · | $-456.0K | · | · | |
| Levered FCF | · | · | · | · | · | $9M | · | · | · | $8M | · | · | · | $-1M | · | · |
Rentowność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | 28.8% | · | 27.7% | 28.8% | 28.4% | · | 28.6% | 30.0% | 28.6% | · | 27.5% | 29.6% | 29.4% | · | 26.3% | |
| Operating Margin | · | 15.2% | · | 15.1% | 16.1% | 15.6% | · | 17.1% | 16.3% | 15.2% | · | 14.9% | 17.0% | 13.1% | · | 26.8% | |
| Net Margin | · | 11.3% | · | 10.6% | 11.4% | 11.6% | · | 11.3% | 12.3% | 12.1% | · | 11.6% | 11.9% | 10.0% | · | 20.2% | |
| Pretax Margin | · | 14.0% | · | 13.6% | 14.3% | 13.7% | · | 14.6% | 15.8% | 14.6% | · | 14.0% | 16.0% | 12.2% | · | 26.0% | |
| EBITDA Margin | · | 15.2% | · | 15.1% | 19.2% | 18.7% | · | 17.1% | 16.3% | 18.0% | · | 14.9% | 17.0% | 16.0% | · | 26.8% | |
| ROA | · | 2.7% | · | 2.5% | 3.2% | 3.3% | · | 3.1% | 3.3% | 3.2% | · | 3.0% | 3.0% | 2.6% | · | 6.4% | |
| ROE | · | 4.4% | · | 4.5% | 4.9% | 5.2% | · | 5.4% | 4.8% | 4.7% | · | 4.7% | 5.1% | 4.4% | · | 9.4% | |
| ROIC | · | 3.3% | · | 3.3% | 3.5% | 3.6% | · | 3.5% | 4.0% | 4.0% | · | 3.9% | 4.0% | 3.4% | · | 6.8% |
Płynność i wypłacalność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 2.9 | · | 2.4 | 2.8 | 2.6 | · | 2.6 | 3.1 | 2.9 | · | 2.5 | 2.6 | 2.4 | · | 2.3 | |
| Quick Ratio | · | 1.5 | · | 1.3 | 1.4 | 1.3 | · | 1.3 | 1.5 | 1.4 | · | 1.2 | 1.3 | 1.3 | · | 1.2 | |
| Debt / Equity | · | 0.3 | · | 0.4 | 0.4 | 0.5 | · | 0.6 | 0.1 | 0.1 | · | 0.2 | 0.2 | 0.2 | · | 0.3 | |
| LT Debt / Equity | · | 0.3 | · | 0.3 | 0.4 | 0.5 | · | 0.6 | 0.1 | 0.1 | · | 0.1 | 0.2 | 0.2 | · | 0.3 | |
| Interest Coverage | · | · | · | · | 9.1 | 8.2 | · | 7.1 | 31.1 | 25.2 | · | 16.1 | 15.6 | 14.8 | · | 30.9 |
Efektywność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.2 | · | 0.2 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | |
| Inventory Turnover | · | 1.2 | · | 1.3 | 1.3 | 1.3 | · | 1.3 | 1.1 | 1.1 | · | 1.2 | 1.2 | 1.4 | · | 1.9 | |
| Receivables Turnover | · | 1.6 | · | 1.8 | 2.1 | 1.9 | · | 1.9 | 1.8 | 1.7 | · | 1.6 | 1.6 | 1.8 | · | 2.1 |
Na akcję
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $56.72 | · | $52.37 | · | $46.80 | · | $42.89 | $40.42 | $38.46 | · | $35.66 | $34.07 | $32.38 | · | $29.84 | |
| Revenue / Share | · | $19.77 | · | $19.87 | $19.45 | $19.05 | · | $18.68 | $14.21 | $13.57 | · | $13.07 | $13.01 | $12.73 | · | $12.70 | |
| Cash Flow / Share | · | $0.41 | · | · | · | $1.78 | · | · | · | $1.38 | · | · | · | $0.22 | · | · | |
| Cash / Share | · | $2.58 | · | $2.36 | · | $1.82 | · | $2.13 | $2.18 | $1.48 | · | $0.83 | $0.69 | $0.85 | · | $1.31 | |
| EPS (TTM) | $9.28 | $8.81 | · | $8.63 | $8.63 | $8.17 | · | $7.01 | $6.42 | $6.22 | · | $5.44 | $6.48 | $6.10 | · | $4.79 |
Wycena (TTM)
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $632M | $609M | · | $598M | $589M | $548M | · | $462M | $417M | $407M | · | $390M | $386M | $380M | · | $319M | |
| Net Income TTM | $72M | $69M | · | $67M | $67M | $63M | · | $54M | $50M | $48M | · | $42M | $50M | $47M | · | $37M | |
| Market Cap | · | $1.50B | · | $1.54B | · | $1.55B | · | $2.43B | $2.03B | $1.93B | · | $1.23B | $1.48B | $988M | · | $651M | |
| Enterprise Value | · | $1.62B | · | $1.67B | · | $1.72B | · | $2.63B | $2.04B | $1.96B | · | $1.27B | $1.53B | $1.04B | · | $712M | |
| P/E | 28.6 | 22.0 | · | 23.1 | 28.3 | 24.7 | · | 45.2 | 41.1 | 40.5 | · | 29.7 | 29.9 | 21.3 | · | 17.9 | |
| P/S | · | 2.5 | · | 2.6 | · | 2.8 | · | 5.3 | 4.9 | 4.7 | · | 3.2 | 3.8 | 2.6 | · | 2.0 | |
| P/B | · | 3.4 | · | 3.8 | · | 4.3 | · | 7.4 | 6.5 | 6.6 | · | 4.5 | 5.7 | 4.0 | · | 2.9 | |
| P / Tangible Book | 15.7 | 14.4 | · | 24.3 | · | 56.6 | · | · | 15.3 | 16.3 | · | 13.1 | 18.3 | 15.0 | · | 14.6 | |
| P / Cash Flow | · | 467.5 | · | · | · | 112.6 | · | · | · | 181.6 | · | · | · | 573.7 | · | · | |
| EV / Revenue | · | 2.7 | · | 2.8 | · | 3.1 | · | 5.7 | 4.9 | 4.8 | · | 3.3 | 4.0 | 2.7 | · | 2.2 | |
| Earnings Yield | 3.5% | 4.5% | · | 4.3% | 3.5% | 4.0% | · | 2.2% | 2.4% | 2.5% | · | 3.4% | 3.3% | 4.7% | · | 5.6% |
Najnowszy okres po lewej · wartości null pokazane jako ·
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Przychody | $603M | $504M | $400M | $354M | $206M |
| Marża Brutto % | 28.3% | 29.1% | 28.1% | 25.5% | 24.8% |
| Marża Operacyjna % | 15.3% | 16.0% | 14.4% | 15.7% | 10.3% |
| Zysk netto | $68M | $59M | $45M | $42M | $16M |
| Rozwodniony EPS | $8.75 | $7.58 | $5.83 | $5.45 | $2.09 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dług / Kapitał Własny | 0.3 | 0.6 | 0.1 | 0.2 | 0.4 |
| Wskaźnik bieżący | 2.7 | 2.6 | 2.5 | 2.1 | 2.5 |
| Wskaźnik Szybkości | 1.4 | 1.3 | 1.2 | 1.1 | 1.5 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | · | $57M | $31M | $4M | $9M |
Właściciele instytucjonalni (13F) 296 emitentów · $2.4B łącznie · Na dzień 30 września 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Posiadacze
296
Wartość posiadanych akcji
$2.4B
Nowe pozycje
39
Zamknięte pozycje
32
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 39 (-3 vs poprzedni kw.) | 32 (+3 vs poprzedni kw.) | 94 (-1 vs poprzedni kw.) | 93 (+6 vs poprzedni kw.) | -53K |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| BlackRock, Inc. | $302 622 035 | 1 141 410 | 12,43% | Akcje |
| CONGRESS ASSET MANAGEMENT CO | $182 260 702 | 687 439 | 7,49% | Akcje |
| WASATCH ADVISORS LP | $150 487 797 | 777 313 | 6,18% | Akcje |
| NEUBERGER BERMAN GROUP LLC | $142 384 885 | 537 038 | 5,85% | Akcje |
| VANGUARD GROUP INC | $118 470 323 | 533 578 | 4,87% | Akcje |
| Boston Trust Walden Corp | $89 157 386 | 336 278 | 3,66% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $87 392 946 | 329 623 | 3,59% | Akcje |
| STATE STREET CORP | $82 935 580 | 312 811 | 3,41% | Akcje |
| AMERICAN CENTURY COMPANIES INC | $74 230 610 | 279 976 | 3,05% | Akcje |
| UBS Group AG | $67 539 216 | 254 740 | 2,77% | Akcje |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $59 249 662 | 223 474 | 2,43% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $53 284 151 | 200 933 | 2,19% | Akcje |
| Allspring Global Investments Holdings, LLC | $52 584 093 | 195 720 | 2,16% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $49 396 356 | 186 313 | 2,03% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $42 743 728 | 161 218 | 1,76% | Akcje |
| AltraVue Capital, LLC | $39 097 647 | 147 466 | 1,61% | Akcje |
| MORGAN STANLEY | $32 979 085 | 124 387 | 1,35% | Akcje |
| FRANKLIN RESOURCES INC | $30 242 848 | 114 068 | 1,24% | Akcje |
| Swedbank AB | $27 972 541 | 105 505 | 1,15% | Akcje |
| ASHFORD CAPITAL MANAGEMENT INC | $27 843 953 | 105 020 | 1,14% | Akcje |
| GENEVA CAPITAL MANAGEMENT LLC | $27 318 401 | 103 038 | 1,12% | Akcje |
| ENVESTNET ASSET MANAGEMENT INC | $26 074 607 | 98 347 | 1,07% | Akcje |
| Annex Advisory Services, LLC | $25 244 182 | 130 394 | 1,04% | Akcje |
| NORTHERN TRUST CORP | $24 195 763 | 91 260 | 0,99% | Akcje |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | $22 423 370 | 84 575 | 0,92% | Akcje |
| RENAISSANCE TECHNOLOGIES LLC | $22 394 205 | 84 465 | 0,92% | Akcje |
| Owls Nest Partners IA, LLC | $19 813 430 | 74 731 | 0,81% | Akcje |
| De Lisle Partners LLP | $19 677 115 | 74 302 | 0,81% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $19 428 461 | 73 279 | 0,80% | Akcje |
| ROYAL BANK OF CANADA | $18 066 000 | 68 136 | 0,74% | Akcje |
| BANK OF AMERICA CORP /DE/ | $15 990 521 | 60 312 | 0,66% | Akcje |
| OSAIC HOLDINGS, INC. | $15 515 929 | 58 522 | 0,64% | Akcje |
| Impax Asset Management Group plc | $14 714 715 | 55 500 | 0,60% | Akcje |
| Diamond Hill Capital Management, LLC (Investment Advisor) | $14 628 813 | 55 176 | 0,60% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $14 582 150 | 55 000 | 0,60% | Akcje |
| PRINCIPAL FINANCIAL GROUP INC | $14 197 712 | 53 550 | 0,58% | Akcje |
| NEW YORK STATE COMMON RETIREMENT FUND | $13 647 567 | 51 475 | 0,56% | Akcje |
| BROWN CAPITAL MANAGEMENT LLC | $13 439 175 | 50 689 | 0,55% | Akcje |
| Applied Fundamental Research, LLC | $13 388 535 | 50 498 | 0,55% | Akcje |
| Rockefeller Capital Management L.P. | $12 274 193 | 46 295 | 0,50% | Akcje |
| RAYMOND JAMES FINANCIAL INC | $12 209 501 | 46 051 | 0,50% | Akcje |
| ROYCE & ASSOCIATES LP | $11 789 005 | 44 465 | 0,48% | Akcje |
| SEI INVESTMENTS CO | $11 715 364 | 44 185 | 0,48% | Akcje |
| Bank of New York Mellon Corp | $11 321 581 | 42 702 | 0,47% | Akcje |
| Congress Wealth Management LLC / DE / | $11 267 249 | 46 147 | 0,46% | Akcje |
| Palisades Investment Partners, LLC | $10 293 937 | 38 826 | 0,42% | Akcje |
| RENAISSANCE GROUP LLC | $9 895 447 | 37 323 | 0,41% | Akcje |
| Ranger Investment Management, L.P. | $9 552 634 | 36 030 | 0,39% | Akcje |
| Legato Capital Management LLC | $9 359 354 | 35 301 | 0,38% | Akcje |
| RICE HALL JAMES & ASSOCIATES, LLC | $9 023 434 | 34 034 | 0,37% | Akcje |
Aktywiści i właściciele 5%+ 9 akcji
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Ancora Advisors, LLC ×4 zgłoszenia | 4 kwietnia 2019 | · | Pierwotne zgłoszenie | · | SEC |
| Thomas E. Lynch, Scott P. Scharfman, Mill Road Capital II GP LLC, Mill Road Capital II, L.P. | 19 września 2016 | · | Pierwotne zgłoszenie | · | SEC |
| Mill Road Capital II, L.P., Mill Road Capital II GP LLC, Thomas E. Lynch, Scott P. Scharfman | 19 lutego 2016 | · | Pierwotne zgłoszenie | Inwestycja pasywna | SEC |
| Nantahala Capital Management, LLC (2) | 25 lipca 2011 | · | Pierwotne zgłoszenie | · | SEC |
| Boston Avenue Capital, LLC, Yorktown Avenue Capital, LLC, Value Fund Advisors, LLC, Charles M. Gillman ×2 zgłoszenia | 13 marca 2007 | · | Pierwotne zgłoszenie | Inwestycja pasywna | SEC |
| Yorktown Avenue Capital, LLC, Value Fund Advisors, LLC, Charles M. Gillman | 15 maja 2006 | · | Pierwotne zgłoszenie | Inwestycja pasywna | SEC |
| R. Jeffrey Bailly ×2 zgłoszenia | 24 marca 2006 | · | Pierwotne zgłoszenie | · | SEC |
| Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca | 26 lutego 2001 | · | Pierwotne zgłoszenie | · | SEC |
| Niezgłoszona osoba raportująca | 14 lutego 2001 | · | Pierwotne zgłoszenie | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insiderzy spółki 28 insiderów · 7 dyrektorzy generalni · 7 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Ronald J Lataille | Chief Financial Officer | 4 czerwca 2026 A | 20 352 | 0 | 0 | $0 |
| Mitchell Rock | President | 4 czerwca 2026 A | 39 115 | 0 | 0 | $0 |
| Jeffrey R Bailly | Executive Chairman | 10 sierpnia 2026 S | 0 | 0 | 7 | $-9 110 272 |
| Jason Holt | Vice President | 6 sierpnia 2026 S | 7 878 | 0 | 2 | $-370 058 |
| Ryan K Stafford | SVP Human Resources | 4 czerwca 2026 A | 1 448 | 0 | 0 | $0 |
| Christopher P. Litterio | Senior Vice President | 2 marca 2026 F | 11 977 | 0 | 10 | $-415 550 |
| Steve Cardin | Vice President | 3 marca 2025 F | 5 623 | 0 | 0 | $0 |
| Marc D Kozin | Dyrektor | 25 sierpnia 2026 S | 21 112 | 0 | 2 | $-2 131 474 |
| Symeria Hudson | Dyrektor | 18 sierpnia 2026 S | 927 | 0 | 2 | $-720 236 |
| Cynthia L Feldmann | Dyrektor | 13 sierpnia 2026 S | 4 476 | 0 | 3 | $-611 409 |
| Joseph John Hassett | Dyrektor | 4 czerwca 2026 A | 2 425 | 0 | 0 | $0 |
| Thomas Oberdorf | Dyrektor | 4 czerwca 2026 A | 13 219 | 0 | 0 | $0 |
| Daniel C Croteau | Dyrektor | 4 czerwca 2026 A | 1 657 | 0 | 1 | $-634 977 |
| Robert W Pierce Jr | · | 9 czerwca 2021 A | 63 518 | 0 | 0 | $0 |
| Lucia Luce Quinn | · | 9 czerwca 2021 A | 6 086 | 0 | 0 | $0 |
| Daniel J Shaw | · | 1 marca 2021 F | 12 090 | 0 | 0 | $0 |
| David W Smith | · | 2 marca 2020 F | 17 829 | 0 | 0 | $0 |
| David K Stevenson | · | 5 maja 2017 M | 18 103 | 0 | 0 | $0 |
| Kenneth L Gestal | · | 23 listopada 2015 M | 3 329 | 0 | 0 | $0 |
| David Bartlett Gould | · | 6 maja 2015 M | 58 506 | 0 | 0 | $0 |
| Richard Lesavoy | · | 14 maja 2013 S | 103 426 | 0 | 0 | $0 |
| Richard L Bailly | · | 8 czerwca 2011 A | 19 734 | 0 | 0 | $0 |
| Michael John Ross | · | 4 czerwca 2008 A | · | 0 | 0 | $0 |
| Yorktown Avenue Capital, LLC | · | 27 listopada 2006 P | 171 153 | 0 | 0 | $0 |
| William Shaw | · | 17 sierpnia 2006 S | 288 924 | 0 | 0 | $0 |
| WORRELL PETER R | · | 8 czerwca 2006 A | 0 | 0 | 0 | $0 |
| William C Curry | · | 16 maja 2006 M | 7 252 | 0 | 0 | $0 |
| Wayne G Williams | · | 16 maja 2005 A | 53 731 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Posiadanie ETF-ów Posiadane przez 43 fundusze ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| CSMD · Professionally Managed Portfolios | 2,63% | 46 829 NS | 31 lipca 2026 | N-PORT |
| PSCH · Invesco Exchange-Traded Fund Trust … | 1,25% | 7 355 SH | 2 października 2026 | Dziennie |
| RZG · Invesco Exchange-Traded Fund Trust | 0,59% | 2 372 SH | 2 października 2026 | Dziennie |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,38% | 19 485 NS | 31 lipca 2026 | N-PORT |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0,23% | 5 394 NS | 31 lipca 2026 | N-PORT |
| VIOG · VANGUARD ADMIRAL FUNDS | 0,22% | 9 209 SH | 19 sierpnia 2026 | Dziennie |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0,16% | 1 249 SH | 2 października 2026 | Dziennie |
| IWO · iShares Trust | 0,14% | 71 575 SH | 11 września 2026 | Dziennie |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,12% | 6 581 NS | 31 lipca 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,12% | 8 178 SH | 19 sierpnia 2026 | Dziennie |
| VIOO · VANGUARD ADMIRAL FUNDS | 0,11% | 27 070 SH | 19 sierpnia 2026 | Dziennie |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,09% | 794 SH | 2 października 2026 | Dziennie |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,08% | 1 765 NS | 31 lipca 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,08% | 2 098 NS | 31 lipca 2026 | N-PORT |
| ISCG · iShares Trust | 0,07% | 2 445 SH | 11 września 2026 | Dziennie |
| IWM · iShares Trust | 0,07% | 195 393 SH | 11 września 2026 | Dziennie |
| RSSL · Global X Funds | 0,06% | 3 651 NS | 31 lipca 2026 | N-PORT |
| EBIT · Harbor ETF Trust | 0,06% | 29 NS | 31 lipca 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,06% | 43 885 SH | 19 sierpnia 2026 | Dziennie |
| RILA · Spinnaker ETF Series | 0,06% | 92 NS | 31 lipca 2026 | N-PORT |
| ESML · iShares Trust | 0,06% | 5 810 SH | 11 września 2026 | Dziennie |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,05% | 4 798 SH | 2 października 2026 | Dziennie |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0,04% | 2 900 SH | 2 października 2026 | Dziennie |
| DFAS · Dimensional ETF Trust | 0,04% | 24 396 NS | 31 lipca 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,03% | 22 024 SH | 19 sierpnia 2026 | Dziennie |
| FHLC · FIDELITY COVINGTON TRUST | 0,03% | 3 446 NS | 31 lipca 2026 | N-PORT |
| WSML · iShares Trust | 0,02% | 503 SH | 11 września 2026 | Dziennie |
| VXF · VANGUARD INDEX FUNDS | 0,02% | 88 733 SH | 19 sierpnia 2026 | Dziennie |
| DXUV · Dimensional ETF Trust | 0,01% | 290 NS | 31 lipca 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,01% | 17 693 NS | 31 lipca 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0,01% | 4 860 NS | 31 lipca 2026 | N-PORT |
| TILT · FlexShares Trust | 0,01% | 668 NS | 31 lipca 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,01% | 844 NS | 31 lipca 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 1 656 NS | 31 lipca 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 2 373 NS | 31 lipca 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 9 801 SH | 11 września 2026 | Dziennie |
| IWV · iShares Trust | 0,00% | 2 031 SH | 9 września 2026 | Dziennie |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 233 328 SH | 19 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 624 SH | 19 sierpnia 2026 | Dziennie |
| IJR · iShares Trust | · | 472 245 SH | 10 września 2026 | Dziennie |
| IJT · iShares Trust | · | 73 060 SH | 9 września 2026 | Dziennie |
| XJR · iShares Trust | · | 1 074 SH | 31 sierpnia 2026 | Dziennie |
| ISCB · iShares Trust | · | 349 SH | 11 września 2026 | Dziennie |
UFPT Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
ocena · 10 analityków
KUP
Średni cel
$355.00
+18,1%
2 20,0%
Mocne kupno
5 50,0%
Kup
3 30,0%
Trzymaj
0 0,0%
Sprzedaj
0 0,0%
Mocna sprzedaż
12-miesięczny cel cenowy
2 analityków · 2026-10-05Średnia cel $355.00 +18,1%
← Poniżej wszystkich celów
Aktualna cena $300.70
Niski$350.00
Średnia$355.00
Wysoki$360.00
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
Podstawa R/R, ceny według zamknięcia z ostatniego końca roku obrotowego każdej spółki.
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| UFPT | $1.71B | 25.4 | 19.5% | 11.3% | 16.9% | 28.3% |
| HAE | $2.45B | 26.4 | -2.0% | 7.3% | 11.8% | 59.0% |
| QDEL | $1.99B | -1.8 | -1.9% | -41.4% | -48.0% | · |
| ICUI | $3.52B | 4755.7 | -6.3% | 0.03% | 0.03% | 36.8% |
| XRAY | $2.28B | -3.8 | -3.0% | -16.2% | -36.4% | 50.0% |
| NEOG | $1.95B | -224.2 | -2.7% | -0.91% | -0.38% | 46.9% |
| STAA | $1.17B | -14.6 | -23.7% | -33.6% | -23.6% | 76.2% |
| BVS | · | 22.5 | -0.91% | 4.0% | 13.7% | 68.3% |
| KIDS | $446M | -10.5 | 15.4% | -16.8% | -11.3% | 73.0% |
| CERS | $396M | -25.8 | 16.1% | -6.7% | -26.0% | · |
Sygnały transakcyjne Ostatnie sygnały kupna/sprzedaży z ceną wejścia i wskaźnikiem ryzyka/zysku
Obecnie brak otwartego sygnału — żadna karta nie jest wypełniona, i to jest uczciwe.
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
Wybierz wskaźniki, które są dla Ciebie ważne — kliknij + obok dowolnego wiersza w sekcji Pełne dane fundamentalne powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Źródło: SEC 10-Q złożone Sie 6, 2026